Chemed (CHE)
(Delayed Data from NYSE)
$577.77 USD
-3.78 (-0.65%)
Updated Oct 7, 2024 04:00 PM ET
After-Market: $578.68 +0.91 (0.16%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
CHE 577.77 -3.78(-0.65%)
Will CHE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CHE
AMED or CHE: Which Is the Better Value Stock Right Now?
Why Chemed (CHE) is a Top Growth Stock for the Long-Term
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Chemed (CHE) is a Top Growth Stock for the Long-Term
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Other News for CHE
Chemed Larger Than S&P 500 Component Mosaic
CHE Makes Notable Cross Below Critical Moving Average
Exxon Mobil, Chemed, Las Vegas Sands And More On CNBC's 'Final Trades'
Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)
Chemed management to meet with Oppenheimer